Back to search
FDAFDA · Food and drugs·Recall number Z-2239-2026

HydroMARK Breast Biopsy Site Marker, Model Number: 4010-02-15-T3

Published June 3, 2026 · Recall initiated: April 24, 2026

Summary

FDA records medical device Class II recall Z-2239-2026, published June 3, 2026 and initiated April 24, 2026. Recalling firm: Devicor Medical Products Inc; Status: Ongoing; Reported quantity: 1910 units; Lot: Lot Number: F12607207D. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Incorrect inner package labeling. Boxes labeled 4010-02-15-T3 markers may contain individual packages labeled as T4 Markers.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Devicor Medical Products Inc
Distributor
Worldwide distribution - US Nationwide and the countries of Canada, Singapore.
Lot
Lot Number: F12607207D
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was HydroMARK Breast Biopsy Site Marker, Model Number: 4010-02-15-T3 recalled?

Yes. FDA published recall Z-2239-2026 on June 3, 2026. Reported hazard: Incorrect inner package labeling. Boxes labeled 4010-02-15-T3 markers may contain individual packages labeled as T4 Markers.

What should I do if I have this product?

Voluntary: Firm initiated · Letter